Vincent de Jager

Vincent de Jager is a researcher at the University of Groningen's Faculty of Medical Sciences within the Department of Medical Oncology. His work focuses on advancing liquid biopsy applications in oncology, particularly for non-small cell lung cancer management.

His research interests center on circulating tumor DNA analysis, predictive biomarker validation, and targeted therapy optimization. He investigates epidermal growth factor receptor mutations, biological markers for treatment response, and implementation challenges of liquid biopsy in clinical workflows. His fingerprint reveals deep expertise in non-small cell lung cancer (100%), epidermal growth factor receptor (60%), neoplasms (59%), biological markers (56%), targeted therapy (55%), and predictive biomarkers (54%).

Recent publications demonstrate his leadership in developing consensus guidelines for molecular test reporting through the European Liquid Biopsy Society. His work bridges laboratory research with clinical implementation, focusing on standardization challenges and cross-national adoption of liquid biopsy technologies. Key themes include analytical validation, clinical interpretation frameworks, and healthcare system variations in precision oncology.

His professional activities include participation in Molecular Tumor Boards, where he contributes to complex treatment decision-making for rare cancer variants. He collaborates extensively across European institutions on biomarker testing initiatives and liquid biopsy standardization efforts.